The EMA has strengthened information sharing arrangements with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Source: Reactions, 15 September 2012, vol. 1, no. 1419, pp. 5-5(1)

Publisher:

Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Keywords: Adverse-drug-reactions; Adverse-reaction-monitoring; Drug-abuse; Pharmacovigilance

Document Type: Short Communication

Publication date: September 15, 2012

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page